The 10 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 66.00, with a high estimate of 79.00 and a low estimate of 51.00. The median estimate represents a +41.42% increase from the last price of 46.67.
The current consensus among 10 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.54
Reporting Date Mar 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.